Abstract
Rights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
Jay C. Shiao, Nathan Bowers, Tahseen H. Nasti, Faisal Khosa
Abstract
Rights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Combined targeting of costimulatory (OX40) and coinhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust antitumor immunity
10.1158/2326-6066.cir-13-0031-t · 2014
Interleukin-7 and anti-programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression
10.1097/shk.0000000000000317 · 2015
Combining radiation and immunotherapy for synergistic antitumor therapy
2009
Combining radiotherapy and immunotherapy: A revived partnership
10.1016/j.ijrobp.2005.06.032 · 2005
Systemic effects of local radiotherapy
10.1016/s1470-2045(09)70082-8 · 2009
Radiotherapy increases the permissiveness of established mammary tumors to rejection by immunomodulatory antibodies
10.1158/0008-5472.can-12-0210 · 2012
Local tumor treatment in combination with systemic ipilimumab immunotherapy prolongs overall survival in patients with advanced malignant melanoma
10.1158/2326-6066.cir-15-0156 · 2016
Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy
10.4161/onci.28780 · 2014
Focal radiation therapy combined with 4-1BB activation and CTLA-4 blockade yields long-term survival and a protective antigen-specific memory response in a murine glioma model
10.1371/journal.pone.0101764 · 2014
4-1BB aptamer-based immunomodulation enhances the therapeutic index of radiation therapy in murine tumor models
10.1016/j.ijrobp.2016.05.013 · 2016
Augmented antitumor effects of radiation therapy by 4-1BB antibody (BMS-469492) treatment
2006
4-1BB agonists: Multi-potent potentiators of tumor immunity
10.3389/fonc.2015.00117 · 2015
Combination of 4-1BB agonist and PD-1 antagonist promotes antitumor effector/memory CD8 T cells in a poorly immunogenic tumor model
10.1158/2326-6066.cir-14-0118 · 2015
Therapeutic PD-1 pathway blockade augments with other modalities of immunotherapy T-cell function to prevent immune decline in ovarian cancer
10.1158/0008-5472.can-13-1550 · 2013
Concomitant targeting of programmed death-1 (PD-1) and CD137 improves the efficacy of radiotherapy in a mouse model of human BRAFV600-mutant melanoma
10.1007/s00262-016-1843-4 · 2016
Use of oligonucleotide aptamer ligands to modulate the function of immune receptors
10.1158/1078-0432.ccr-12-2067 · 2013
No additional external references are available.